Insulet Investor Says Device Production Issues Tanked Stock
By Lauren Berg · July 2, 2026, 6:17 PM EDT
Insulet Corp. artificially inflated the price of its shares by not disclosing to investors issues with its manufacturing procedures, leading the insulin-delivery device company to initiate medical device corrections and take...
To view the full article, register now.